Washington, DC 7/19/18—Genomic technology firm Bionano Genomics will offer 3,350,000 shares at a price of $8–$10 per share for its IPO (see IBO 6/30/18). The company expects to raise $38.5 million. The company will trade on the NASDAQ exchange under the symbol “BNGO.” Underwriters will be given the option to purchase up to 502,500 additional shares of common stock. The company is scheduled to go public on August 1. In the first half the year, company revenues grew 31.7% to $5.2 million. Net loss declined 41.1% to $7.2 million.